Home/Filings/4/0001628280-20-000991
4//SEC Filing

Fair Richard A. 4

Accession 0001628280-20-000991

CIK 0001358403other

Filed

Feb 3, 7:00 PM ET

Accepted

Feb 4, 2:24 PM ET

Size

5.5 KB

Accession

0001628280-20-000991

Insider Transaction Report

Form 4
Period: 2020-02-03
Fair Richard A.
DirectorPresident and CEO
Transactions
  • Award

    Stock Option (right to buy)

    2020-02-03+1,257,0001,257,000 total
    Exercise: $1.36Exp: 2030-02-02Common Stock (1,257,000 underlying)
Footnotes (1)
  • [F1]25% of the shares subject to the stock option vest and become exercisable on February 3, 2021, and the remaining shares subject to the stock option vest and become exercisable in 36 equal monthly installments thereafter.

Issuer

BELLICUM PHARMACEUTICALS, INC

CIK 0001358403

Entity typeother

Related Parties

1
  • filerCIK 0001695851

Filing Metadata

Form type
4
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 2:24 PM ET
Size
5.5 KB